Symeres Revenue and Competitors

Nijmegen,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Symeres's estimated annual revenue is currently $135.5M per year.(i)
  • Symeres's estimated revenue per employee is $201,000

Employee Data

  • Symeres has 674 Employees.(i)
  • Symeres grew their employee count by 0% last year.

Symeres's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Controller a.i.Reveal Email/Phone
3
VP Business DevelopmentReveal Email/Phone
4
Head Business DevelopmentReveal Email/Phone
5
Head HR a.i.Reveal Email/Phone
6
Director Business Development EuropeReveal Email/Phone
7
Director Marketing & CommunicationsReveal Email/Phone
8
Quality Assurence officerReveal Email/Phone
9
Director Medical ChemistryReveal Email/Phone
10
Director Medicinal ChemistryReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Symeres?

Symeres is the leading mid-sized European Contract Research Organization for your drug-discovery and development challenges. With over 500 scientists, we offer best-in-class solutions for drug discovery and drug development, from small to medium-sized molecule hits. Our services span across early stage hit finding all the way to the delivery of your early clinical drug substance API. We blend vast scientific knowledge with inventiveness to make great leaps on your behalf. We Make Molecules Matter.

keywords:N/A

N/A

Total Funding

674

Number of Employees

$135.5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Symeres News

2022-04-17 - Nirvana Announces First Production of Psilocybin and Psilocin

Symeres is one of the largest European small molecule CRO & CDMOs, providing R&D services and manufacturing to major pharmaceutical and...

2022-03-22 - NIRVANA ENTERS SUPPLY AGREEMENT WITH SYMERES

Symeres is one of the largest European small molecule CRO & CDMOs, providing R&D services and manufacturing to major pharmaceutical and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$311.1M15484%N/A
#2
$1678.4M42686%$814.9M